
Dry Eye
Latest News

Cyclosporine ophthalmic solution 0.09% Phase 4 data indicates sustained improvement in dry eye signs, symptoms in patients switched from cyclosporine ophthalmic emulsion 0.05%
Latest Videos

CME Content
More News

An expert ophthalmologist presents patient cases from her practice, demonstrating how light adjustable lenses have achieved remarkable outcomes for those with diverse corneal topographies.

An ophthalmology specialist discusses factors to consider when choosing premium intraocular lenses and effectively communicating these choices to patients.

Educating patients about the importance of consistent care is key.

An expert underscores the importance of a comprehensive dry eye examination and offers insights on distinguishing it from neurotrophic keratitis.

An expert examines a case involving a young male patient interested in LASIK treatment but facing meibomian gland atrophy.

An expert discusses the key considerations for addressing dry eye in a patient who has undergone multiple ocular procedures.

An expert presents a case of dry eye in a patient who has undergone several eye surgeries and now requires cataract surgery.

Clinicians must screen, diagnose, and manage for effective treatment.

Mile Brujic, OD, FAAO, discusses the use of specialty lenses vs glasses in some patients, as well as approaches to managing the symptoms of dry eye disease.

Mile Brujic, OD, FAAO, presents a patient case of a 67-year-old woman with dry eye disease and a history of radial keratotomy (RK) surgery.

Mile Brujic, OD, FAAO, shares considerations from a patient case, highlighting diagnostic tools in dry eye disease as well as the ability of the patient to use medication.

Mile Brujic, OD, FAAO, presents the case of a 42-year-old female patient with dry eye disease who has discomfort using eyedrops.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 4 of the Viewpoints Podcast.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in part 3 of the Viewpoints Podcast.

Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease in the second part of the Viewpoints Podcast.

In this podcast, Bill B. Trattler, MD, Crystal Brimer, OD, Cynthia Matossian, MD, FACS, and Kelly K. Nichols, OD, MPH, PhD, discuss dry eye disease and the various approaches clinicians can take to treat the disease.

Walgreens Boots Allianc Inc. and CVS Health are among the companies the FDA sent letters to for violating federal law.

According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution) is the first prescription eye drop that targets tear evaporation.

The study examines the effectiveness of PL9643 for the treatment of patients with dry eye disease.

OKYO Pharma reaches 90% enrollment mark in Phase 2 clinical trial of OK-101 to treat dry eye disease
According to the company, full enrollment anticipated by first week of September. The phase 2 trial is designed as potential registration trial with pre-specified primary efficacy endpoints covering both a sign and symptom of DED.

In this podcast episode, Ophthalmology Times' co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of Demodex blepharitis. Through personal anecdotes, they stress its underrecognized gravity and discuss diagnostic cues like collarettes. The experts share their enthusiasm for improved treatments, echoing the transformative impact seen in dry eye care.

The organization says to stop using Dr. Berne’s and LightEyez MSM drops immediately due to bacterial contamination, fungal contamination, or both.

For clinicians, the evolution of treatment is as much a responsibility as an opportunity.

Treating the meibomian glands and lifestyle changes are among some of the treatment methods.






































